Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-686
Closed -$385K 1213
2025
Q4
$385K Buy
686
+202
+42% +$115K 0.02% 1015
2025
Q3
$249K Sell
484
-1,785
-79% -$779K 0.02% 1279
2025
Q2
$712K Buy
2,269
+961
+73% +$289K 0.07% 442
2025
Q1
$399K Buy
1,308
+975
+293% +$328K 0.04% 627
2024
Q4
$111K Sell
333
-449
-57% -$152K 0.01% 1066
2024
Q3
$261K Sell
782
-1,361
-64% -$517K 0.02% 957
2024
Q2
$883K Buy
2,143
+1,258
+142% +$498K 0.12% 278
2024
Q1
$358K Buy
885
+261
+42% +$91.8K 0.06% 467
2023
Q4
$191K Buy
+624
New +$168K 0.04% 634

Other funds holding MEDP

AlphaQuest's MEDP Position: Q1 2026 in Review

AlphaQuest sold out of Medpace (MEDP) in Q1 2026, closing a stake of 686 shares — an estimated $385K sold.

AlphaQuest first reported a position in MEDP in Q4 2023 and held it in 9 quarters. The position peaked at $883K in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • AlphaQuest reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 686 Medpace shares in Q1 2026, an estimated $385K.
  • AlphaQuest first reported a position in Medpace in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Medpace position peaked at $883K in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.